Ads
related to: rbc- Expertise
Our Expertise Ranges Across a Large
Set of Industries and Markets
- About Us
RBC's History, Culture & Values
Learn More
- Consumer and Retail
Will the rush for new tech trigger
retail M&A?
- M&A's 2024 Comeback
Steady interest rate environment is
laying the ground for M&A recovery.
- ECM's 2024 Rebound
Equity markets are poised for a
rebound in 2024.
- Insights
Get Insights From RBC Experts on
Industry Sectors & Future Outlooks
- Expertise
Search results
RBC Hires $915 Million Advisor Team From Truist
Barrons.com· 3 hours agoRBC Wealth Management recruited a former Truist Financial advisor team overseeing approximately $915 million in client assets. “We chose to move our...
RBC Capital lowers Tesla shares target amid robotaxi market reassessment By Investing.com
Investing.com· 11 hours agoOn Thursday, RBC Capital adjusted its outlook on Tesla (NASDAQ:TSLA) shares, reducing the electric...
Tesla Stock Is Falling
Barrons.com· 8 hours agoRBC analyst Tom Narayan cut his price target on Tesla stock to $227 from $293 while keeping his Buy rating. He’s adjusted his robotaxi math.Read the full...
Tesla target cut at RBC Capital after revisiting robotaxi By Investing.com
Investing.com· 9 hours agoRBC Capital analysts lowered their price target for Tesla (NASDAQ:TSLA) to $227 per share, down from...
KB Home shares target raised by RBC Capital on strong 2Q performance By Investing.com
Investing.com· 11 hours agoOn Thursday, RBC Capital adjusted its outlook on KB Home (NYSE:KBH) shares, raising the price target...
Here's Why RBC Bearings (NYSE:RBC) Has Caught The Eye Of Investors
Simply Wall St. via Yahoo Finance· 8 hours agoDespite being in the age of tech-stock blue-sky investing, many investors still adopt a more...
Financial Services Roundup: Market Talk
The Wall Street Journal· 2 hours ago(kirk.maltais@wsj.com; @kirkmaltais) 1405 ET – KB Home’s stock is looking inexpensive right now relative to its return on tangible equity, RBC Capital...
RBC Bearings (NASDAQ:ROLL) Earns Hold Rating from Analysts at StockNews.com
ETF DAILY NEWS· 22 hours agoEquities researchers at StockNews.com initiated coverage on shares of RBC Bearings (NASDAQ:ROLL – Get Free Report) in a note issued to investors on Thursday. The firm set ...
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
CNBC· 8 hours agoGilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial,...
Gilead Flashes Bullish Sign After HIV Drug Proves 100% Effective
Investor's Business Daily· 7 hours agoExperimental drug lenacapavir is an under-the-skin shot twice a year. "Our market research had...
Ads
related to: rbc
